Skip to main content

Table 2 Prevalence of MetS by levels of different status markers and multiple logistic regression analysis of MetS and the associated factors based on ATPIII-modified criteria in the rural population of Liaoning Province, China

From: An update on the prevalence of metabolic syndrome and its associated factors in rural northeast China

 

Male

Female

Total

Variables

N

Pre (%)

OR (95% CI)

N

Pre (%)

OR (95% CI)

N

Pre (%)

OR (95% CI)

Age group

         

35-44

373

30.9

1.00(reference)

411

26.9

1.00(reference)

784

28.7

1.00(reference)

45-54

509

31.7

1.01(0.86,1.19)

854

43.4

1.95(1.68,2.27)

1363

38.1

1.49(1.33,1.67)

55-64

530

32.6

0.99(0.83,1.19)

1033

56.3

2.86(2.41,3.39)

1563

45.2

1.81(1.60,2.05)

≥65

873

29.3

0.77(0.61,0.97)

522

61.1

3.20(2.56,3.99)

778

45.0

1.64(1.40,1.91)

Numbers of child

         

≤1

683

31.3

1.00(reference)

917

37.6

1.00(reference)

1600

34.6

1.00(reference)

>1

985

31.5

1.03(0.90,1.17)

1903

50.8

1.20(1.06,1.35)

2888

42.0

1.13(1.04,1.24)

Ethnicity

         

Han

1588

31.6

1.00(reference)

2690

45.8

1.00(reference)

4278

39.3

1.00(reference)

Othersa

80

28.4

0.82(0.62,1.08)

130

41.1

0.91(0.72,1.17)

210

35.1

0.87(0.73,1.05)

Educational status

         

Primary school or below

666

30.1

1.00(reference)

1811

51.5

1.00(reference)

2477

43.3

1.00(reference)

Middle school

765

30.7

0.98(0.86,1.13)

824

37.5

0.84(0.74,0.95)

1589

33.9

0.88(0.80,0.96)

High school or above

237

39.0

1.31(1.07,1.60)

185

38.9

0.84(0.68,1.04)

422

39.0

1.034(0.89,1.20)

Physical activity

         

Light

444

37.0

1.00(reference)

1133

51.0

1.00(reference)

1577

46.1

1.00(reference)

Moderate

1121

29.4

0.75(0.65,0.87)

1505

41.7

0.87(0.77,0.97)

2626

35.3

0.81(0.74,0.89)

Severe

103

35.2

0.96(0.72,1.26)

182

51.6

1.19(0.94,1.51)

285

44.1

1.06(0.89,1.27)

Annual income (CNY/year)

         

≤5000

202

28.4

1.00(reference)

378

52.8

1.00(reference)

580

40.6

1.00(reference)

5000-20000

851

29.9

1.11(0.91,1.34)

1563

45.8

0.99(0.83,1.18)

2414

38.6

1.03(0.91,1.17)

>20000

615

35.1

1.35(1.09,1.66)

879

42.8

1.08(0.89,1.32)

1494

39.2

1.19(1.03,1.36)

Sleep duration (h/d)

         

≤7

764

30.8

1.00(reference)

1536

46.7

1.00(reference)

2300

39.9

1.00(reference)

7-8

485

31.5

1.05(0.91,1.21)

713

41.9

0.99(0.88,1.13)

1198

37.0

1.01(0.92,1.11)

8-9

255

31.4

1.05(0.88,1.26)

368

47.9

1.23(1.04,1.46)

623

39.4

1.12(0.99,1.27)

>9

164

34.5

1.23(0.99,1.52)

203

47.1

1.23(0.99,1.52)

367

40.5

1.18(1.02,1.37)

Marriage

         

No

111

26.9

1.00(reference)

287

51.9

1.00(reference)

398

41.2

1.00(reference)

Yesb

1557

31.8

1.18(0.93,1.51)

2533

45.0

1.21(0.99,1.47)

4090

38.8

1.10(0.95,1.28)

Current smoking status

         

No

783

34.3

1.00(reference)

2363

45.8

1.00(reference)

3146

42.3

1.00(reference)

Yes

885

29.2

0.78(0.69,0.89)

457

44.5

0.78(0.67,0.90)

1342

33.1

0.84(0.76,0.92)

Current drinking status

         

No

941

32.5

1.00(reference)

2752

45.8

1.00(reference)

3693

41.5

1.00(reference)

Yes

727

30.2

0.96(0.85,1.09)

68

37.2

0.76(0.55,1.04)

795

39.7

0.99(0.88,1.11)

Cardiovascular disease c

         

No

1439

30.4

1.00(reference)

2139

42.7

1.00(reference)

3578

36.7

1.00(reference)

Yes

229

40.3

1.44(1.19,1.74)

681

58.0

1.40(1.21,1.61)

910

52.2

1.44(1.28,1.60)

Cerebrovascular disease d

         

No

1442

30.0

1.00(reference)

2459

43.5

1.00(reference)

3901

37.3

1.00(reference)

Yes

215

43.9

1.78(1.45,2.18)

357

68.4

1.94(1.58,2.38)

572

56.5

1.82(1.58,2.09)

Chronic kidney disease e

         

No

1609

31.0

1.00(reference)

2690

44.9

1.00(reference)

4299

38.5

1.00(reference)

Yes

30

46.9

1.55(0.93,2.61)

52

59.1

1.09(0.68,1.73)

82

53.9

1.36(0.96,1.92)

Diet score

         

<3

695

31.3

1.00(reference)

1744

47.8

1.00(reference)

2439

41.6

1.00(reference)

≥3

973

31.5

1.01(0.89,1.15)

1076

42.3

0.91(0.82,1.02)

2049

36.4

0.97(0.89,1.05)

Beans or Bean products intake (Frequence/week)

         

Rarely

501

28.4

1.00(reference)

1251

45.4

1.00(reference)

1752

38.8

1.00(reference)

2-3times

925

32.0

1.17(1.02,1.33)

1262

45.3

1.03(0.92,1.16)

2221

38.7

1.09(0.99,1.18)

≥4times

242

36.7

1.42(1.17,1.73)

273

47.5

1.12(0.92,1.36)

515

41.7

1.24(1.09,1.43)

Tea intake (Frequence/day)

         

No

788

29.7

1.00(reference)

2160

46.5

1.00(reference)

2948

40.4

1.00(reference)

rarely

458

33.4

1.20(1.04,1.38)

393

43.0

1.08(0.93,1.26)

851

37.2

1.11(1.00,1.23)

1-2 times

356

32.9

1.21(1.03,1.42)

245

43.4

1.03(0.85,1.24)

601

36.5

1.11(0.99,1.26)

3-4 times

66

33.2

1.18(0.86,1.63)

22

36.1

0.88(0.51,1.53)

88

33.8

1.03(0.79,1.36)

  1. aIncluding some ethnic minorities in China, such as Mongol and Manchu.
  2. bIncluding widowed, divorced/separated and unmarried.
  3. cCardiovascular disease include angina, myocardia infarction, arrhythmia, heart failure.
  4. dCerebrovascular disease include cerebral hemorrhage, cerebral infarction, subarachnoid hemorrhage, Transient Ischemic Attack.
  5. eChronic kidney disease nephritis, acute/chronic renal failure.
  6. Italic and bold mean P <0.05; Bold only means P <0.001; CNY, China Yuan (1CNY = 0.161 USD); Abbreviations: OR odds ratio, 95% CI 95% confidence interval.
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us